Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

364

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

September 30, 2016

Conditions
Acne Vulgaris
Interventions
DRUG

IDP-120 Gel

IDP-120 Gel is a combination product

DRUG

IDP 120 Component A Gel

Monad of Component A

DRUG

IDP 120 Component B Gel

Monad of Component B

DRUG

IDP 120 Vehicle Gel

Vehicle

Trial Locations (24)

10001

Valreant Site 05, New York

10002

Valeant Site 06, New York

27268

Valeant Site 17, High Point

27517

Valeant Site 01, Chapel Hill

30302

Valeant Site 21, Atlanta

32746

Valeant Site 13, Lake Mary

33101

Valeant Site 16, Miami

33401

Valeant Site 02, West Palm Beach

33601

Valeant Site 14, Tampa

37901

Valeant Site 04, Knoxville

43085

Valeant Site 22, Columbus

46601

Valeant Site 23, South Bend

48204

Valeant Site 09, Detroit

55401

Valeant Site 24, Minneapolis

64502

Valeant Site 11, Saint Joseph

73301

Valeant Site 07, Austin

78204

Valeant Site 18, San Antonio

78701

Valeant Site 12, Austin

91316

Valeant Site 15, Encino

99202

Valeant Site 25, Spokane

R2C 0A1

Valeant Site 10, Winnepeg

L3P 0A1

Valeant Site 03, Markham

N2J 1L9

Valeant Site 08, Waterloo

N9A 2S6

Valeant Site 20, Windsor

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT03003247 - Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris | Biotech Hunter | Biotech Hunter